Resultados de la búsqueda 71-80 of 12554 for Vas+deferens

  1. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate the safety and feasibility of concentrated bone marrow aspirate administration after Comprehensive Arthroscopic ...

  2. Neurología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate the safety, pharmacokinetics and biodistribution of an imaging agent, 18F-OP-801 (18F Hydroxyl Dendrimer), ...

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to assess the differences in microvascular anastomosis outcomes between the experiment aneurysmal subarachnoid ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  5. Mayo Clinic Digestive Diseases Physician Update - November 2024

    Page 1.

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...

  7. Cáncer de próstata - Médicos y departamentos - Mayo Clinic

    707 4.293 8 8.9 ">Diag.707 43586 12.293 4.293 13.707 5.707 8 11.414z">&quodb0EAmp.707 4.293 8 8.586 12.293 4.293 lass="aem-GridColumn aem7"-iiiogo,umn aem- ...

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    The primary purpose of this study is to map the electrophysiological properties of deep brain stimulation (DBS) targets and associated areas by analyzing ...

  9. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  10. Transplant Center de Mayo Clinic - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to attempt to improve outcomes after kidney transplantation and to improve the safety of living kidney donation ...